JP2005514171A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005514171A5 JP2005514171A5 JP2003559568A JP2003559568A JP2005514171A5 JP 2005514171 A5 JP2005514171 A5 JP 2005514171A5 JP 2003559568 A JP2003559568 A JP 2003559568A JP 2003559568 A JP2003559568 A JP 2003559568A JP 2005514171 A5 JP2005514171 A5 JP 2005514171A5
- Authority
- JP
- Japan
- Prior art keywords
- patch
- surgical
- agent
- surgical patch
- releases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 claims 11
- 229940121363 anti-inflammatory agent Drugs 0.000 claims 6
- 239000002260 anti-inflammatory agent Substances 0.000 claims 6
- 229940123587 Cell cycle inhibitor Drugs 0.000 claims 5
- 239000003146 anticoagulant agent Substances 0.000 claims 5
- 239000003795 chemical substances by application Substances 0.000 claims 5
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 claims 4
- 229940123237 Taxane Drugs 0.000 claims 4
- 229940127219 anticoagulant drug Drugs 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 4
- 239000003527 fibrinolytic agent Substances 0.000 claims 4
- DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 claims 4
- VSNHCAURESNICA-NJFSPNSNSA-N 1-oxidanylurea Chemical compound N[14C](=O)NO VSNHCAURESNICA-NJFSPNSNSA-N 0.000 claims 2
- YZEUHQHUFTYLPH-UHFFFAOYSA-N 2-nitroimidazole Chemical compound [O-][N+](=O)C1=NC=CN1 YZEUHQHUFTYLPH-UHFFFAOYSA-N 0.000 claims 2
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical group CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 claims 2
- KLWPJMFMVPTNCC-UHFFFAOYSA-N Camptothecin Natural products CCC1(O)C(=O)OCC2=C1C=C3C4Nc5ccccc5C=C4CN3C2=O KLWPJMFMVPTNCC-UHFFFAOYSA-N 0.000 claims 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims 2
- 102000007625 Hirudins Human genes 0.000 claims 2
- 108010007267 Hirudins Proteins 0.000 claims 2
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 claims 2
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 claims 2
- 229930192392 Mitomycin Natural products 0.000 claims 2
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 claims 2
- 229930012538 Paclitaxel Natural products 0.000 claims 2
- 108010023197 Streptokinase Proteins 0.000 claims 2
- DPOPAJRDYZGTIR-UHFFFAOYSA-N Tetrazine Chemical compound C1=CN=NN=N1 DPOPAJRDYZGTIR-UHFFFAOYSA-N 0.000 claims 2
- 108090000373 Tissue Plasminogen Activator Proteins 0.000 claims 2
- 102000003978 Tissue Plasminogen Activator Human genes 0.000 claims 2
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 claims 2
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 claims 2
- 229940122803 Vinca alkaloid Drugs 0.000 claims 2
- 229960001138 acetylsalicylic acid Drugs 0.000 claims 2
- 229940045799 anthracyclines and related substance Drugs 0.000 claims 2
- 230000001028 anti-proliverative effect Effects 0.000 claims 2
- 229940127093 camptothecin Drugs 0.000 claims 2
- VSJKWCGYPAHWDS-FQEVSTJZSA-N camptothecin Chemical compound C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-FQEVSTJZSA-N 0.000 claims 2
- UHDGCWIWMRVCDJ-ZAKLUEHWSA-N cytidine Chemical class O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-ZAKLUEHWSA-N 0.000 claims 2
- VSJKWCGYPAHWDS-UHFFFAOYSA-N dl-camptothecin Natural products C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)C5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-UHFFFAOYSA-N 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- YJGVMLPVUAXIQN-UHFFFAOYSA-N epipodophyllotoxin Natural products COC1=C(OC)C(OC)=CC(C2C3=CC=4OCOC=4C=C3C(O)C3C2C(OC3)=O)=C1 YJGVMLPVUAXIQN-UHFFFAOYSA-N 0.000 claims 2
- 239000004052 folic acid antagonist Substances 0.000 claims 2
- 239000003862 glucocorticoid Substances 0.000 claims 2
- 229960002897 heparin Drugs 0.000 claims 2
- 229920000669 heparin Polymers 0.000 claims 2
- WQPDUTSPKFMPDP-OUMQNGNKSA-N hirudin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(OS(O)(=O)=O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2)=O)CSSC1)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)CSSC1)C(C)C)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 WQPDUTSPKFMPDP-OUMQNGNKSA-N 0.000 claims 2
- 229940006607 hirudin Drugs 0.000 claims 2
- 229960001680 ibuprofen Drugs 0.000 claims 2
- HAWPXGHAZFHHAD-UHFFFAOYSA-N mechlorethamine Chemical class ClCCN(C)CCCl HAWPXGHAZFHHAD-UHFFFAOYSA-N 0.000 claims 2
- 229960004961 mechlorethamine Drugs 0.000 claims 2
- 229960004857 mitomycin Drugs 0.000 claims 2
- 229960001592 paclitaxel Drugs 0.000 claims 2
- 150000003058 platinum compounds Chemical class 0.000 claims 2
- 229960001237 podophyllotoxin Drugs 0.000 claims 2
- YJGVMLPVUAXIQN-XVVDYKMHSA-N podophyllotoxin Chemical compound COC1=C(OC)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@H](O)[C@@H]3[C@@H]2C(OC3)=O)=C1 YJGVMLPVUAXIQN-XVVDYKMHSA-N 0.000 claims 2
- YVCVYCSAAZQOJI-UHFFFAOYSA-N podophyllotoxin Natural products COC1=C(O)C(OC)=CC(C2C3=CC=4OCOC=4C=C3C(O)C3C2C(OC3)=O)=C1 YVCVYCSAAZQOJI-UHFFFAOYSA-N 0.000 claims 2
- 229920000642 polymer Polymers 0.000 claims 2
- 125000000561 purinyl group Chemical class N1=C(N=C2N=CNC2=C1)* 0.000 claims 2
- 150000003230 pyrimidines Chemical class 0.000 claims 2
- 229960005202 streptokinase Drugs 0.000 claims 2
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 claims 2
- 229960000187 tissue plasminogen activator Drugs 0.000 claims 2
- 229960005356 urokinase Drugs 0.000 claims 2
- 230000002792 vascular Effects 0.000 claims 2
- 230000003110 anti-inflammatory effect Effects 0.000 claims 1
- 230000000702 anti-platelet effect Effects 0.000 claims 1
- 229940045719 antineoplastic alkylating agent nitrosoureas Drugs 0.000 claims 1
- 229940127218 antiplatelet drug Drugs 0.000 claims 1
- 239000011248 coating agent Substances 0.000 claims 1
- 238000000576 coating method Methods 0.000 claims 1
- 238000007598 dipping method Methods 0.000 claims 1
- 230000003480 fibrinolytic effect Effects 0.000 claims 1
- OSTGTTZJOCZWJG-UHFFFAOYSA-N nitrosourea Chemical compound NC(=O)N=NO OSTGTTZJOCZWJG-UHFFFAOYSA-N 0.000 claims 1
- 238000005507 spraying Methods 0.000 claims 1
- 229920002994 synthetic fiber Polymers 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34401101P | 2001-12-28 | 2001-12-28 | |
| PCT/CA2002/002017 WO2003059408A2 (en) | 2001-12-28 | 2002-12-30 | Surgical patches with a biological active agent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005514171A JP2005514171A (ja) | 2005-05-19 |
| JP2005514171A5 true JP2005514171A5 (cg-RX-API-DMAC7.html) | 2006-02-16 |
Family
ID=23348648
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003559568A Pending JP2005514171A (ja) | 2001-12-28 | 2002-12-30 | 生物学的活性薬剤を有する外科用パッチ |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20030216758A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1465680A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2005514171A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20050025136A (cg-RX-API-DMAC7.html) |
| CN (2) | CN1276780C (cg-RX-API-DMAC7.html) |
| AU (1) | AU2002351632A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR0215397A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2470499A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA04006319A (cg-RX-API-DMAC7.html) |
| NZ (2) | NZ533499A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2003059408A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050084514A1 (en) * | 2000-11-06 | 2005-04-21 | Afmedica, Inc. | Combination drug therapy for reducing scar tissue formation |
| CN101134119A (zh) * | 2002-05-24 | 2008-03-05 | 血管技术国际股份公司 | 用于涂覆医用植入物的组合物和方法 |
| US8313760B2 (en) | 2002-05-24 | 2012-11-20 | Angiotech International Ag | Compositions and methods for coating medical implants |
| AU2003275263A1 (en) * | 2002-09-26 | 2004-04-19 | Angiotech International Ag | Perivascular wraps |
| US20050158356A1 (en) * | 2003-11-20 | 2005-07-21 | Angiotech International Ag | Implantable sensors and implantable pumps and anti-scarring agents |
| US20050209664A1 (en) * | 2003-11-20 | 2005-09-22 | Angiotech International Ag | Electrical devices and anti-scarring agents |
| US8293890B2 (en) * | 2004-04-30 | 2012-10-23 | Advanced Cardiovascular Systems, Inc. | Hyaluronic acid based copolymers |
| US9833618B2 (en) * | 2005-02-04 | 2017-12-05 | Palo Alto Investors | Methods and compositions for treating a disease condition in a subject |
| US20080020014A1 (en) * | 2006-07-19 | 2008-01-24 | Paul Consigny | Implantable devices containing nuclear receptor ligands for the treatment of vascular and related disorders |
| US20080039362A1 (en) * | 2006-08-09 | 2008-02-14 | Afmedica, Inc. | Combination drug therapy for reducing scar tissue formation |
| US20090173352A1 (en) * | 2007-11-01 | 2009-07-09 | Pavad Medical | On-off implant for supporting the airway |
| CA2706881A1 (en) | 2007-11-30 | 2009-06-11 | Brian Z. Ring | Tle3 as a marker for chemotherapy |
| US8690960B2 (en) * | 2009-11-24 | 2014-04-08 | Covidien Lp | Reinforced tissue patch |
| ES2606958T3 (es) | 2010-05-14 | 2017-03-28 | Dana-Farber Cancer Institute, Inc. | Compuestos de tienotriazolodiazepina para tratar una neoplasia |
| CN103180318B (zh) | 2010-05-14 | 2017-05-10 | 达那-法伯癌症研究所 | 雄性避孕组合物以及使用方法 |
| CN103154246B (zh) | 2010-05-14 | 2015-11-25 | 达那-法伯癌症研究所 | 用于治疗白血病的组合物和方法 |
| CN103619177A (zh) * | 2011-04-25 | 2014-03-05 | 南加州大学 | 通过抑制干扰素-γ和肿瘤坏死因子-α来改善组织再生的方法和组合物 |
| CN102698319A (zh) * | 2012-03-02 | 2012-10-03 | 首都医科大学附属北京朝阳医院 | 一种抗肿瘤生物补片 |
| WO2014159392A1 (en) | 2013-03-14 | 2014-10-02 | Dana-Farber Cancer Institute, Inc. | Bromodomain binding reagents and uses thereof |
| WO2014186435A2 (en) | 2013-05-14 | 2014-11-20 | University Of Georgia Research Foundation, Inc. | Compositions and methods for reducing neointima formation |
| BR112016001457A2 (pt) | 2013-07-25 | 2017-08-29 | Dana Farber Cancer Inst Inc | Inibidores de fatores de transcrição e usos dos mesmos |
| US11446309B2 (en) | 2013-11-08 | 2022-09-20 | Dana-Farber Cancer Institute, Inc. | Combination therapy for cancer using bromodomain and extra-terminal (BET) protein inhibitors |
| MX2016009974A (es) | 2014-01-31 | 2016-10-31 | Dana Farber Cancer Inst Inc | Derivados de diaminopirimidina bencensulfona y sus usos. |
| WO2015117083A1 (en) | 2014-01-31 | 2015-08-06 | Dana-Farber Cancer Institute, Inc. | Diazepane derivatives and uses thereof |
| EP3099693A4 (en) | 2014-01-31 | 2017-08-16 | Dana-Farber Cancer Institute, Inc. | Uses of diazepane derivatives |
| WO2015131113A1 (en) | 2014-02-28 | 2015-09-03 | Tensha Therapeutics, Inc. | Treatment of conditions associated with hyperinsulinaemia |
| WO2016022970A1 (en) | 2014-08-08 | 2016-02-11 | Dana-Farber Cancer Institute, Inc. | Dihydropteridinone derivatives and uses thereof |
| RU2017104897A (ru) | 2014-08-08 | 2018-09-10 | Дана-Фарбер Кэнсер Инститьют, Инк. | Производные диазепана и их применения |
| UA122130C2 (uk) | 2014-10-27 | 2020-09-25 | Тенша Терапеутікс, Інк. | Інгібітори бромодомену |
| CA2986441A1 (en) | 2015-06-12 | 2016-12-15 | Dana-Farber Cancer Institute, Inc. | Combination therapy of transcription inhibitors and kinase inhibitors |
| RU2018112953A (ru) | 2015-09-11 | 2019-10-14 | Дана-Фарбер Кэнсер Инститьют, Инк. | Ацетамидтиенотриазолодиазепины и пути их применения |
| US11306105B2 (en) | 2015-09-11 | 2022-04-19 | Dana-Farber Cancer Institute, Inc. | Cyano thienotriazolodiazepines and uses thereof |
| CR20180336A (es) | 2015-11-25 | 2018-08-06 | Dana Farber Cancer Inst Inc | Inhibidores de bromodominio bivalentes y usos de los mismos |
| CN109821076B (zh) * | 2019-03-13 | 2021-05-07 | 陕西师范大学 | 一种抗凝抗感染的多功能涂层的制备方法及抗凝抗感染的多功能材料 |
| KR20220009041A (ko) | 2020-07-15 | 2022-01-24 | 문현우 | 당뇨병 환자를 위한 상처 치유 억제용 패치 |
Family Cites Families (95)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3894000A (en) * | 1971-01-27 | 1975-07-08 | Upjohn Co | Ara-cytidine derivatives and process of preparation |
| CH614720A5 (cg-RX-API-DMAC7.html) * | 1974-10-15 | 1979-12-14 | Asahi Chemical Ind | |
| DE2623420C2 (de) * | 1976-05-25 | 1978-07-06 | Stiftung Deutsches Krebsforschungszentrum, 6900 Heidelberg | Verfahren zur Herstellung unsymmetrisch 13-disubstituierter Nitrosoharnstoffe |
| US4258052A (en) * | 1976-08-17 | 1981-03-24 | Yu Ruey J | Treatment of psoriasis with nicotinamide analogues |
| US4215062A (en) * | 1978-05-22 | 1980-07-29 | University Of Kansas Endowment Association | Anthracycline synthesis |
| US4296105A (en) * | 1978-08-03 | 1981-10-20 | Institut International De Pathologie Cellulaire Et Moleculaire | Derivatives of doxorubicine, their preparation and use |
| US4371540A (en) * | 1979-09-14 | 1983-02-01 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Nitroimidazoles of low toxicity and high activity as radiosensitizers of hypoxic tumor cells |
| US4367239A (en) * | 1980-09-29 | 1983-01-04 | Kefalas A/S | Nitrosourea derivatives, pharmaceutical compositions thereof and method of preparation |
| JPS5775993A (en) * | 1980-10-30 | 1982-05-12 | Tetsuo Suami | Novel nitrosourea derivative and its preparation |
| US4394373A (en) * | 1981-04-06 | 1983-07-19 | Malette William Graham | Method of achieving hemostasis |
| US4462992A (en) * | 1982-02-08 | 1984-07-31 | Research Corporation | Nitroimidazole radiosensitizers for hypoxic tumor cells and compositions thereof |
| US4500676A (en) * | 1983-12-15 | 1985-02-19 | Biomatrix, Inc. | Hyaluronate modified polymeric articles |
| US4636524A (en) * | 1984-12-06 | 1987-01-13 | Biomatrix, Inc. | Cross-linked gels of hyaluronic acid and products containing such gels |
| US4582865A (en) * | 1984-12-06 | 1986-04-15 | Biomatrix, Inc. | Cross-linked gels of hyaluronic acid and products containing such gels |
| US5128326A (en) * | 1984-12-06 | 1992-07-07 | Biomatrix, Inc. | Drug delivery systems based on hyaluronans derivatives thereof and their salts and methods of producing same |
| US5099013A (en) * | 1985-03-12 | 1992-03-24 | Biomatrix, Inc, | Hylan preparation and method of recovery thereof from animal tissues |
| US4841045A (en) * | 1985-03-12 | 1989-06-20 | University Of Vermont & State Agricultural College | Synthesis of vinblastine and vincristine type compounds |
| US5215738A (en) * | 1985-05-03 | 1993-06-01 | Sri International | Benzamide and nicotinamide radiosensitizers |
| EP0232693A3 (fr) * | 1985-12-16 | 1988-04-06 | La Region Wallonne | Conjugués de la vinblastine et de ses dérivés, procédé pour leur préparation et compositions pharmaceutiques les contenant |
| US4841085A (en) * | 1986-06-30 | 1989-06-20 | Board Of Regents, University Of Texas System | Aldophosphamides |
| FR2601675B1 (fr) * | 1986-07-17 | 1988-09-23 | Rhone Poulenc Sante | Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent |
| FR2601676B1 (fr) * | 1986-07-17 | 1988-09-23 | Rhone Poulenc Sante | Procede de preparation du taxol et du desacetyl-10 taxol |
| US4913743A (en) * | 1987-04-15 | 1990-04-03 | Biomatrix, Inc. | Processes for managing keratinous material using glycosaminoglycan and cationic polymer combinations |
| US4838888A (en) * | 1987-04-17 | 1989-06-13 | Baxter Travenol Laboratories, Inc. | Calcification mitigation of implantable bioprostheses |
| US4795741A (en) * | 1987-05-06 | 1989-01-03 | Biomatrix, Inc. | Compositions for therapeutic percutaneous embolization and the use thereof |
| US5527337A (en) * | 1987-06-25 | 1996-06-18 | Duke University | Bioabsorbable stent and method of making the same |
| US5532220A (en) * | 1987-08-31 | 1996-07-02 | The Regents Of The University Of California | Genetic mechanisms of tumor suppression |
| US4942184A (en) * | 1988-03-07 | 1990-07-17 | The United States Of America As Represented By The Department Of Health And Human Services | Water soluble, antineoplastic derivatives of taxol |
| US4908356A (en) * | 1988-05-25 | 1990-03-13 | Research Corporation Technologies, Inc. | Aldophosphamide derivatives useful as antitumor agents |
| US5104400A (en) * | 1989-05-26 | 1992-04-14 | Impra, Inc. | Blood vessel patch |
| US5100422A (en) * | 1989-05-26 | 1992-03-31 | Impra, Inc. | Blood vessel patch |
| DE3924424A1 (de) * | 1989-07-24 | 1991-01-31 | Boehringer Mannheim Gmbh | Nucleosid-derivate, verfahren zu deren herstellung, deren verwendung als arzneimittel sowie deren verwendung bei der nucleinsaeure-sequenzierung |
| ATE147613T1 (de) * | 1989-09-15 | 1997-02-15 | Chiron Vision Corp | Synthetisches material, das die anlagerung, das wachstum und die befestigung von epithelzellen fördert, prosthetische vorrichtung zur subepithelialen implantation sowie behandelte linse |
| US5525348A (en) * | 1989-11-02 | 1996-06-11 | Sts Biopolymers, Inc. | Coating compositions comprising pharmaceutical agents |
| JP2839164B2 (ja) * | 1989-12-25 | 1998-12-16 | 帝國製薬株式会社 | 消炎鎮痛貼付剤 |
| AU7998091A (en) * | 1990-05-17 | 1991-12-10 | Harbor Medical Devices, Inc. | Medical device polymer |
| US5833665A (en) * | 1990-06-14 | 1998-11-10 | Integra Lifesciences I, Ltd. | Polyurethane-biopolymer composite |
| US5594158A (en) * | 1990-06-22 | 1997-01-14 | The Board Of Regents Of The University Of Nebraska | Processes for producing doxorubicin, daunomycinone, and derivatives of doxorubicin |
| US5143724A (en) * | 1990-07-09 | 1992-09-01 | Biomatrix, Inc. | Biocompatible viscoelastic gel slurries, their preparation and use |
| US5246698A (en) * | 1990-07-09 | 1993-09-21 | Biomatrix, Inc. | Biocompatible viscoelastic gel slurries, their preparation and use |
| US5278324A (en) * | 1990-08-28 | 1994-01-11 | Virginia Tech Intellectual Properties, Inc. | Water soluble derivatives of taxol |
| TW197439B (cg-RX-API-DMAC7.html) * | 1991-04-04 | 1993-01-01 | Ueno Pharmaceutics Applic Res Co Ltd | |
| US5889169A (en) * | 1991-05-16 | 1999-03-30 | Cold Spring Harbor Laboratory | Cell cycle regulatory protein p16 gene |
| DE69223065T2 (de) * | 1991-06-14 | 1998-04-09 | Gore & Ass | Oberflächenmodifiziertes, poröses expandiertes polytetrafluoroäthylen und verfahren zur herstellung desselben |
| CA2071160A1 (en) * | 1991-07-31 | 1993-02-01 | Vittorio Farina | Asymmetric synthesis of taxol side chain |
| US5283253A (en) * | 1991-09-23 | 1994-02-01 | Florida State University | Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them |
| US5350866A (en) * | 1991-09-23 | 1994-09-27 | Bristol-Myers Squibb Company | 10-desacetoxytaxol derivatives |
| US5811447A (en) * | 1993-01-28 | 1998-09-22 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
| US5500013A (en) * | 1991-10-04 | 1996-03-19 | Scimed Life Systems, Inc. | Biodegradable drug delivery vascular stent |
| AU667069B2 (en) * | 1991-12-06 | 1996-03-07 | North Shore University Hospital Research Corporation | Method of reducing medical device related infections |
| US5222964A (en) * | 1992-03-03 | 1993-06-29 | Cooper William I | Intraluminal stent |
| US5200534A (en) * | 1992-03-13 | 1993-04-06 | University Of Florida | Process for the preparation of taxol and 10-deacetyltaxol |
| US5440056A (en) * | 1992-04-17 | 1995-08-08 | Abbott Laboratories | 9-deoxotaxane compounds |
| US5248796A (en) * | 1992-06-18 | 1993-09-28 | Bristol-Myers Squibb Company | Taxol derivatives |
| US5294637A (en) * | 1992-07-01 | 1994-03-15 | Bristol-Myers Squibb Company | Fluoro taxols |
| US5202448A (en) * | 1992-08-14 | 1993-04-13 | Napro Biotherapeutics, Inc. | Processes of converting taxanes into baccatin III |
| WO1994005282A1 (en) * | 1992-09-04 | 1994-03-17 | The Scripps Research Institute | Water soluble taxol derivatives |
| US5411984A (en) * | 1992-10-16 | 1995-05-02 | Virginia Tech Intellectual Properties, Inc. | Water soluble analogs and prodrugs of taxol |
| US5552156A (en) * | 1992-10-23 | 1996-09-03 | Ohio State University | Liposomal and micellular stabilization of camptothecin drugs |
| AU5605994A (en) * | 1992-11-12 | 1994-06-08 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Methods for determining the presence of functional p53 in mammalian cells |
| US5380751A (en) * | 1992-12-04 | 1995-01-10 | Bristol-Myers Squibb Company | 6,7-modified paclitaxels |
| US5279949A (en) * | 1992-12-07 | 1994-01-18 | Board Of Trustees Operating Michigan State University | Process for the isolation and purification of taxol and taxanes from Taxus spp |
| US5382582A (en) * | 1993-03-26 | 1995-01-17 | Chan; Carcy L. | Methotrexate analogs and methods of using same |
| US5399352A (en) * | 1993-04-14 | 1995-03-21 | Emory University | Device for local drug delivery and methods for using the same |
| US5412092A (en) * | 1993-04-23 | 1995-05-02 | Bristol-Myers Squibb Company | N-substituted 2-azetidinones |
| US5994341A (en) * | 1993-07-19 | 1999-11-30 | Angiogenesis Technologies, Inc. | Anti-angiogenic Compositions and methods for the treatment of arthritis |
| CA2167715C (en) * | 1993-07-20 | 1998-10-06 | Akiyoshi Kawai | Heteroaryl cycloalkenyl hydroxyureas |
| US5380299A (en) * | 1993-08-30 | 1995-01-10 | Med Institute, Inc. | Thrombolytic treated intravascular medical device |
| US5653730A (en) * | 1993-09-28 | 1997-08-05 | Hemodynamics, Inc. | Surface opening adhesive sealer |
| US5395850A (en) * | 1994-03-10 | 1995-03-07 | Bristol-Myers Squibb Company | 6,7-epoxy paclitaxels |
| FI951367A7 (fi) * | 1994-03-28 | 1995-09-29 | Japan Energy Corp | Puriinijohdannaiset ja tulehdustautien tukahduttajat (suppressantit) |
| DE69419265T2 (de) * | 1994-07-27 | 2000-01-05 | W.L. Gore & Associates, Inc. | Höchfeste poröse folie aus ptfe |
| US6033847A (en) * | 1995-02-06 | 2000-03-07 | St. Jude Children's Research Hospital | InK4c-p18 and InK4d-p19, inhibitors of cyclin-dependent kinases CDK4 and CDK6, and uses thereof |
| US6025480A (en) * | 1995-04-03 | 2000-02-15 | Sloan-Kettering Institute For Cancer Research | Isolated nucleic acid molecules encoding P57KIP2 |
| US6099562A (en) * | 1996-06-13 | 2000-08-08 | Schneider (Usa) Inc. | Drug coating with topcoat |
| AU716005B2 (en) * | 1995-06-07 | 2000-02-17 | Cook Medical Technologies Llc | Implantable medical device |
| US5609629A (en) * | 1995-06-07 | 1997-03-11 | Med Institute, Inc. | Coated implantable medical device |
| US5723313A (en) * | 1995-09-27 | 1998-03-03 | St. Jude Children's Research Hospital | ARF-p19, a novel regulator of the mammalian cell cycle |
| EP0874643B1 (en) * | 1996-02-15 | 2001-11-21 | J. Paul Santerre | Bioresponsive pharmacologically-active polymers and articles made therefrom |
| US5744349A (en) * | 1996-03-05 | 1998-04-28 | Washington University | DNA sequences encoding human Myt1 kinase |
| US5942555A (en) * | 1996-03-21 | 1999-08-24 | Surmodics, Inc. | Photoactivatable chain transfer agents and semi-telechelic photoactivatable polymers prepared therefrom |
| US5800412A (en) * | 1996-10-10 | 1998-09-01 | Sts Biopolymers, Inc. | Hydrophilic coatings with hydrating agents |
| US6106473A (en) * | 1996-11-06 | 2000-08-22 | Sts Biopolymers, Inc. | Echogenic coatings |
| US5879697A (en) * | 1997-04-30 | 1999-03-09 | Schneider Usa Inc | Drug-releasing coatings for medical devices |
| US6110483A (en) * | 1997-06-23 | 2000-08-29 | Sts Biopolymers, Inc. | Adherent, flexible hydrogel and medicated coatings |
| US6121027A (en) * | 1997-08-15 | 2000-09-19 | Surmodics, Inc. | Polybifunctional reagent having a polymeric backbone and photoreactive moieties and bioactive groups |
| GB9719426D0 (en) * | 1997-09-13 | 1997-11-12 | Johnson Matthey Plc | Novel process |
| US6197036B1 (en) * | 1997-10-01 | 2001-03-06 | Scimed Life Systems, Inc. | Pelvic floor reconstruction |
| US6100032A (en) * | 1998-03-13 | 2000-08-08 | Johns Hopkins University | Human Smad3 and Smad4 are sequence-specific transcription activators |
| PT1019111E (pt) * | 1998-04-27 | 2002-10-31 | Surmodics Inc | Revestimento que liberta um agente bioactivo |
| US6120847A (en) * | 1999-01-08 | 2000-09-19 | Scimed Life Systems, Inc. | Surface treatment method for stent coating |
| US6528107B2 (en) * | 1999-01-19 | 2003-03-04 | Sulzer Carbomedics Inc. | Method for producing antimicrobial antithrombogenic medical devices |
| US6224579B1 (en) * | 1999-03-31 | 2001-05-01 | The Trustees Of Columbia University In The City Of New York | Triclosan and silver compound containing medical devices |
| US6545097B2 (en) * | 2000-12-12 | 2003-04-08 | Scimed Life Systems, Inc. | Drug delivery compositions and medical devices containing block copolymer |
| EP1247537A1 (en) * | 2001-04-04 | 2002-10-09 | Isotis B.V. | Coating for medical devices |
-
2002
- 2002-12-27 US US10/331,137 patent/US20030216758A1/en not_active Abandoned
- 2002-12-30 EP EP02787305A patent/EP1465680A2/en not_active Ceased
- 2002-12-30 BR BR0215397-1A patent/BR0215397A/pt not_active IP Right Cessation
- 2002-12-30 AU AU2002351632A patent/AU2002351632A1/en not_active Abandoned
- 2002-12-30 KR KR1020047010174A patent/KR20050025136A/ko not_active Withdrawn
- 2002-12-30 JP JP2003559568A patent/JP2005514171A/ja active Pending
- 2002-12-30 NZ NZ533499A patent/NZ533499A/en unknown
- 2002-12-30 NZ NZ546343A patent/NZ546343A/en unknown
- 2002-12-30 MX MXPA04006319A patent/MXPA04006319A/es unknown
- 2002-12-30 CA CA002470499A patent/CA2470499A1/en not_active Abandoned
- 2002-12-30 CN CNB028263707A patent/CN1276780C/zh not_active Expired - Fee Related
- 2002-12-30 CN CNA2006101534035A patent/CN1911453A/zh active Pending
- 2002-12-30 WO PCT/CA2002/002017 patent/WO2003059408A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6572644B1 (en) | Stent mounting device and a method of using the same to coat a stent | |
| US20030113439A1 (en) | Support device for a stent and a method of using the same to coat a stent | |
| US7413746B2 (en) | Stent coatings containing self-assembled monolayers | |
| ES2206486T3 (es) | Dispositivo medico intravascular. | |
| Liu et al. | Blood compatible materials: state of the art | |
| US8042487B2 (en) | System for coating stents | |
| WO2005086831A3 (en) | Endothelial ligand binding coated medical device | |
| US7247313B2 (en) | Polyacrylates coatings for implantable medical devices | |
| US7223286B2 (en) | Local delivery of rapamycin for treatment of proliferative sequelae associated with PTCA procedures, including delivery using a modified stent | |
| CA2637490C (en) | Stent and method for fabricating the same | |
| JP4473390B2 (ja) | ステント及びステントグラフト | |
| US7632307B2 (en) | Abluminal, multilayer coating constructs for drug-delivery stents | |
| ES2330869T3 (es) | Revestimientos medicados para dispositivos medicos implantables que incluyen poliacrilatos. | |
| US20040062853A1 (en) | Mandrel for supporting a stent and a method of using the mandrel to coat a stent | |
| US8864820B2 (en) | Selective coating of an implantable medical device | |
| US20070110891A1 (en) | Apparatus and method for coating implantable devices | |
| Scoutaris et al. | Development and biological evaluation of inkjet printed drug coatings on intravascular stent | |
| US20060280858A1 (en) | Balloon catheter for delivering therapeutic agents | |
| ATE529068T1 (de) | Mehrschichtig beschichteter stent zur kontrollierten freisetzung von wirkstoffen und verfahren zu seiner herstellung | |
| ATE439878T1 (de) | Deckbeschichtung enhaltend heparin für kontrollierte wirkstoffabgabe | |
| CA2408754A1 (en) | Delivery devices for treatment of vascular disease | |
| CN102526861A (zh) | 一种介入医疗器械 | |
| JP2008289853A (ja) | 抗血栓共役体を有する医療装置用のコーティング剤 | |
| JP5611036B2 (ja) | エラストマー性ブロックコポリマーコーティングを有する埋込型医療装置 | |
| AU2002340549B2 (en) | Stents |